Related Experiment Video
Updated: Dec 29, 2025

Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery
Published on: November 14, 2018
Pharmacokinetics of Nanosomal Form of Levodopa in Intranasal Administration
Andrey Anatolievich Nedorubov1, Alexey Nikitich Pavlov1, Natalia Valeryevna Pyatigorskaya1
1Institute of Pharmacy and Translational Medicine, Sechenov First Moscow State Medical University, Trubetskaya Street, 8, Moscow, Russian Federation.
Background:
Parkinson's disease is one of the most common neurological diseases. Pathogenesis of the disease is associated with destruction and death of neurons that produce the neurotransmitter dopamine. The precursor to dopamine, which crosses the protective blood-brain barrier, is the amino acid 3, 4-dihydroxy-L-phenylalanine - levodopa, L-DOPA. The investigational drug is a pharmaceutical composition, containing L-DOPA as an active substance, which is distributed in a polymer matrix based on a biodegradable copolymer of lactic/glycolic acids.
Aim:
This work aimed to study the main pharmacokinetic parameters for the drug "L-DOPA - PC, nasal drops" and comparator drugs "L-DOPA in oil", "L-DOPA - PC in purified water", reference product - tablets "Madopar 125".
Methods:
To increase the bioavailability of the active substance L-DOPA, a new route of administration was used for the first time - nasal administration. Pharmacokinetics of the innovative drug with the intranasal route of administration was investigated in rabbits. The L-DOPA concentration in blood plasma was determined by high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS).
Results:
Bioavailability of the drug - nasal drops were 244.4% compared with the drug "Madopar 125".
Conclusion:
Assay procedure for the determination of L-DOPA in animal blood plasma using liquid chromatography with tandem mass-selective detection (HPLC-MS/MS) was developed and validated.
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drug Delivery: Enteral Route

